FDA: PDUFA VII Performance Goals, Fiscal Years 2023 to 2027 (2022)

Government Record · U.S. Food and Drug Administration · September 2022

FDA, 2022: the commitment letter behind the Prescription Drug User Fee Act. It sets the review deadlines and procedures FDA promises the drug industry in exchange for the fees industry pays.

PDUFA Reauthorization Performance Goals and Procedures Fiscal Years 2023 Through 2027

PDF p. 3
Read the document (PDF)Official source

FDA, 2022: the commitment letter behind the Prescription Drug User Fee Act. It sets the review deadlines and procedures FDA promises the drug industry in exchange for the fees industry pays.

Election Day is Tuesday, Nov 3. Know who you're voting for: your values vs. their record, with sources.Build my Vote Card →